# Therapeutic Exploratory Study of CWP-0403

> **NCT00888719** · PHASE2 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 145 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** CWP-0403 100mg
- **DRUG:** placebo
- **DRUG:** CWP-0403 50mg

## Key facts

- **NCT ID:** NCT00888719
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-01
- **Final completion:** 2010-04
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2010-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888719, "Therapeutic Exploratory Study of CWP-0403". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00888719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*